Dinactin: A New Antitumor Antibiotic with Cell Cycle Progression and Cancer Stemness Inhibiting Activities in Lung Cancer

15 Sep 2023
0

Dinactin: A New Antitumor Antibiotic with Cell Cycle Progression and Cancer Stemness Inhibiting Activities in Lung Cancer

Rawangkan A, Wongsirisin P, Pook-In G, Siriphap A, Yosboonruang A, Kiddee A, Chuerduangphui J, Reukngam N, Duangjai A, Saokaew S, Praphasawat R

Antibiotics. 2022;11(12):1845.

Tags

Share this

Related Posts

Serum Proteomic Profiling Reveals Differentially Expressed IGHG3 and A1AG1 as Potential Predictors of Chemotherapeutic Response in Advanced Non-small Cell Lung Cancer. Mon MM, Srisomsap C, Chokchaichamnankit D, Watcharatanyatip K, Weeraphan C, Svasti J, Maneechai K, Thongsuksai P, Raungrut P*. Anticancer Res. 2021 Apr;41(4):1871-1882.
Khunnawutmanotham, N.; Sahakitpichan, P.; Chimnoi, N.; Techasakul, S. Efficient One-Pot Synthesis of Tetrahydronaphtho[2,1-f]isoquinolines by Using Domino Pictet–Spengler/Friedel–Crafts-Type Reactions. Eur. J. Org. Chem. 2017, 2017, 6434–6440.

Recent Posts